Predictive capacity for local disease control of neogenin-1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma

  • 0Otorhinolaryngology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, C/Mas Casanovas, 90, 08041, Barcelona, Spain.

Summary

This summary is machine-generated.

Lower neogenin-1 (NEO1) gene expression predicts worse local control in head and neck squamous cell carcinoma (HNSCC) patients. Patients with low NEO1 expression face a significantly higher risk of local tumor recurrence after surgery.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background

  • Head and neck squamous cell carcinoma (HNSCC) is a significant global health concern.
  • Identifying reliable biomarkers for predicting treatment outcomes in HNSCC is crucial for personalized medicine.

Purpose Of The Study

  • To investigate the association between neogenin-1 (NEO1) gene transcriptional expression and local disease control in surgically treated HNSCC patients.
  • To determine if NEO1 expression can serve as a predictive marker for local recurrence after surgery.

Main Methods

  • Retrospective analysis of tumor biopsies from 107 HNSCC patients.
  • Quantification of NEO1 transcriptional expression using reverse transcription-polymerase chain reaction (RT-PCR).
  • Recursive partitioning analysis to categorize NEO1 expression levels relative to local disease control.

Main Results

  • Lower NEO1 transcriptional expression was significantly associated with poorer local disease control.
  • Patients with low NEO1 expression exhibited a 5-year local recurrence-free survival of 61.8% compared to 85.6% for those with high expression (P=0.003).
  • Multivariable analysis indicated a 2.7-fold increased risk of local recurrence in patients with lower NEO1 expression (P=0.043).

Conclusions

  • Reduced transcriptional expression of the NEO1 gene is a significant predictor of increased local recurrence risk in HNSCC patients post-surgery.
  • NEO1 expression levels may offer valuable prognostic information for guiding treatment strategies in HNSCC.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes 01:33

8.8K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes II: Tumor Suppressor Genes 01:05

7.4K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

The Retinoblastoma Gene 01:20

4.1K

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...